STOCK TITAN

Faeth Therapeutics: Montanova reports 8.9% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Faeth Therapeutics, Inc. (FTH) is the issuer in an amended beneficial-ownership report covering 2,310,703 shares (8.9%) reported by Montanova Capital, LLC and the same number and percentage reported by Aaron Cowen, plus 1,969,872 shares (7.6%) reported by Averill Master Fund, Ltd. The amounts are reported as of September 30, 2026.

Each reporting person reported zero sole voting and sole dispositive power and shared voting and dispositive power over its stated amount. The securities are directly owned by Montanova advisory clients; no such client other than Averill may be deemed to beneficially own more than 5% of FTH. Each reporting person disclaims beneficial ownership except to the extent of its pecuniary interest.

Beneficially owned shares — Montanova Capital, LLC 2,310,703 shares Reported as of September 30, 2026
Class percentage — Montanova Capital, LLC 8.9% Of the class, as reported
Beneficially owned shares — Averill Master Fund, Ltd. 1,969,872 shares Reported as of September 30, 2026
Class percentage — Averill Master Fund, Ltd. 7.6% Of the class, as reported
Beneficially owned shares — Aaron Cowen 2,310,703 shares Reported as of September 30, 2026
Class percentage — Aaron Cowen 8.9% Of the class, as reported
beneficial ownership regulatory
"disclaims beneficial ownership"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
shared voting power regulatory
"Shared voting power: 2,310,703"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared dispositive power: 2,310,703"
pecuniary interest regulatory
"to the extent of its pecuniary interest"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares of FTH did each reporting person report?

Montanova Capital, LLC and Aaron Cowen each reported 2,310,703 shares, or 8.9%; Averill Master Fund, Ltd. reported 1,969,872 shares, or 7.6%. The amounts are reported as of September 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





81728A207

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Montanova Capital, LLC
Signature:/s/ Andrew Nathanson
Name/Title:Andrew Nathanson, General Counsel and Chief Compliance Officer
Date:11/13/2026
Averill Master Fund, Ltd.
Signature:/s/ Andrew Nathanson
Name/Title:Andrew Nathanson, Authorized Signatory
Date:11/13/2026
Aaron Cowen
Signature:/s/ Aaron Cowen
Name/Title:Aaron Cowen
Date:11/13/2026

Comments accompanying signature: * Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. To the extent that "ownership of 5 percent or less of a class" was indicated in Item 5, such response only applies to the Reporting Person(s) that indicated elsewhere herein that it beneficially owns five percent (5%) or less of the class.
Exhibit Information

Exhibit A - Joint Filing Agreement Exhibit B - Control Person Identification

Keep reading